Both in Pharmaceuticals
Corvus Pharmaceuticals vs Alto Neuroscience
Over the past year CRVS returned +30.6% and ANRO returned +85.7%; their daily moves had a correlation of 0.18.
CRVS +30.6% ANRO +85.7%Growth of $1, one year, split-adjusted
| Metric | CRVS | ANRO |
|---|---|---|
| Price | $10.03 | $22.60 |
| Market cap | $843.7M | $886.9M |
| Today | −1.96% | −3.71% |
| 1 month | −8.2% | −10.7% |
| 6 months | −35.1% | −9.4% |
| Year to date | +30.3% | +27.0% |
| 1 year | +30.6% | +61.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $215.2M | $225.1M |
| Dividend yield | — | — |
| Volatility (60d) | 51.7% | 56.0% |
| Short % of float | 25.5% | 20.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).